Plasma amino acid profile in autism spectrum disorder (ASD)

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 5, 2016, Pages 923-929

  Bala, Keziban Asli ^a   Dogan M ^a   Mutluer, T ^b   Kaba, S ^a   Aslan, O ^a   Balahoroglu R ^a   Cokluk E ^a   Ustyol L ^a   Kocaman, S ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b KOÇ UNIVERSITY   (Turkey)

Author keywords

Adolescent; Autism spectrum disorder; Children; Plasma amino acids

Indexed keywords

3 METHYLHISTIDINE; ALANINE; AMINO ACID; AMMONIA; ARGININE; ASPARAGINE; ASPARTIC ACID; CARNOSINE; CYANOCOBALAMIN; CYSTATHIONINE; CYSTEINE; CYSTINE; ETHANOLAMINE; GLUTAMIC ACID; GLYCINE; HISTIDINE; HOMOCYSTEINE; HYDROXYLYSINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; ORNITHINE; PHENYLALANINE; PHOSPHOETHANOLAMINE; PHOSPHOSERINE; THREONINE; TYROSINE; VITAMIN D;

ADOLESCENT; ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; AUTISM; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PATHOGENESIS; AUTISM SPECTRUM DISORDER; BLOOD; CASE CONTROL STUDY; PRESCHOOL CHILD;

ADOLESCENT; AMINO ACIDS; AUTISM SPECTRUM DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; VITAMIN B 12; VITAMIN D;

EID: 85016943527     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. SILWOOD CJ, LYNCH E, CLAXSON AW, GROOTVELD MC. 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res 2002; 81: 422-427.
2. PREVALENCE OF AUTISM SPECTRUM DISORDERS - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009; 58: 1-20.
3. KOLEVZON A, GROSS R, REICHENBERG A. Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med 2007; 161: 326-333.
4. GARDENER H, SPIEGELMAN D, BUKA SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009; 195: 7-14.
5. CANNELL JJ, GRANT WB. What is the role of vitamin D in autism? Dermatoendocrinol 2013; 5: 199-204.
6. LE COUTEUR A, BAILEY A, GOODE S, PICKLES A, ROBERTSON S, GOTTESMAN I, RUTTER M. A broader phenotype of autism: the clinical spectrum in twins. J Child Psychol Psychiatry 1996; 37: 785-801.
7. WHITE JF. Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 2003; 228: 639-649.
8. BONGIOVANNI B, FEINERMAN J. Amino acid profiling clinical guidelines for determination of preferred specimen choice. Townsend Letter for Doctors and Patients. 2003; pp. 38-43.
9. JAMES SJ, CUTLER P, MELNYK S, JERNIGAN S, JANAK L, GAYLOR DW, NEUBRANDER JA. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004; 80: 1611-1617.
10. CHAUHAN A, CHAUHAN V. Oxidative stress in autism. Pathophysiology 2006; 13: 171-181.
11. DOGAN M, ARIYUCA S, PEKER E, AKBAYRAM S, DOGAN SZ, OZDEMIR O, CESUR Y. Psychotic disorder, hypertension and seizures associated with vitamin B12 deficiency: a case report. Hum Exp Toxicol 2012; 31: 410-413.
12. DOGAN M, OZDEMIR O, SAL EA, DOGAN SZ, OZDEMIR P, CESUR Y, CAKSEN H. Psychotic disorder and extrapyramidal symptoms associated with vitamin B12 and folate deficiency. J Trop Pediatr 2009; 55: 205-207.
13. PASCA SP, NEMES B, VLASE L, GAGYI CE, DRONCA E, MIU AC, DRONCA M. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 2006; 78: 2244-2248.
14. ALDRED S, MOORE KM, FITZGERALD M, WARING RH. Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 2003; 33: 93-97.
15. SHIMMURA C, SUDA S, TSUCHIYA KJ, HASHIMOTO K, OHNO K, MATSUZAKI H, IWATA K, MATSUMOTO K, WAKUDA T, KAMENO Y, SUZUKI K, TSUJII M, NAKAMURA K, TAKEI N, MORI N. Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One 2011; 6: e25340.
16. MORENO-FUENMAYOR H, BORJAS L, ARRIETA A, VALERA V, SOCORRO-CANDANOZA L. Plasma excitatory amino acids in autism. Invest Clin 1996; 37: 113-128.
17. TIROUVANZIAM R, OBUKHANYCH TV, LAVAL J, ARONOV PA, LIBOVE R, BANERJEE AG, PARKER KJ, O'HARA R, HERZENBERG LA, HERZENBERG LA, HARDAN AY. Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders. J Autism Dev Disord 2012; 42: 827-836.
18. SEKI Y, KIMURA M, MIZUTANI N, FUJITA M, AIMI Y, SUZUKI Y. Cerebrospinal fluid taurine after traumatic brain injury. Neurochem Res 2005; 30: 123-128.
19. KLUNK WE, DEBNATH ML, MCCLURE RJ, PETTEGREW JW. Inactivity of phosphoethanolamine, an endogenous GABA analog decreased in Alzheimer's disease, at GABA binding sites. Life Sci 1995; 56: 2377-2383.
20. KLUNK WE, MCCLURE RJ, XU CJ, PETTEGREW JW. Structural determinants of activity at the GABAB receptor. A comparison of phosphoethanolamine and related GABA analogs. Mol Chem Neuropathol 1995; 26: 15-30.
21. LI G, FOOTE C, ALEXANDER S, ALEXANDER H. Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum. Development 2001; 128: 3473-3483.
22. BOEHM G, CERVANTES H, GEORGI G, JELINEK J, SAWATZKI G, WERMUTH B, COLOMBO JP. Effect of increasing dietary threonine intakes on amino acid metabolism of the central nervous system and peripheral tissues in growing rats. Pediatr Res 1998; 44: 900-906.
23. MING X, STEIN TP, BARNES V, RHODES N, GUO L. Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome Res 2012; 11: 5856-5862.